Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 85

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 85
---
    1,135,184

    1,184,389

    Stock-based compensation

    1,003,749

    1,009,011

    Unrealized (gain) on investments, net

    (248,445
    )

    —

    Realized (gain) on investments, net

    (15,625
    )

    —

    Changes in the carrying amount of right-of-use asset

    (1,671
    )

    (418
    )

    Reserve for credit losses

    5,250,000

    —

    Changes in operating assets and liabilities:

    Accounts receivable

    (1,118,061
    )

    953,556

    Deposit for interest reserve

    (5,250,000
    )

    —

    Prepaid expenses and other assets

    432,410

    831,622

    Accounts payable and other liabilities

    1,619,357

    11,874,767

    Operating lease liability

    (326,742
    )

    (56,541
    )

    Net cash used in operating activities

    (22,514,121
    )

    (14,227,428
    )

    Cash flows from investing activities:

    Purchases of property and equipment

    (6,202,600
    )

    (261,617
    )

    Proceeds for sale or maturities of short-term investments

    10,000,000

    —

    Net cash provided by (used in) investing activities

    3,797,400

    (261,617
    )

    Cash flows from financing activities:

    Proceeds from issuance of common stock

    23,739

    6,462,834

    Proceeds from issuance of debt

    —

    6,905,000

    Proceeds from common stock warrants

    —

    2,958,125

    Issuance costs for common stock and warrants

    —

    (638,045
    )

    Debt repayment

    (38,273
    )

    (119,398
    )

    Net cash (used in) provided by financing activities

    (14,534
    )

    15,568,516

    Net (decrease) increase in cash and cash equivalents

    (18,731,255
    )

    1,079,471